Differential effects of metformin-mediated BSEP repression on pravastatin and bile acid pharmacokinetics in humans: A randomized controlled trial.
Krug, Samuel A
Karra, Vijaya Kumari
Kane, Maureen A
Fink, Jeffrey C
Polli, James E
JournalClinical and Translational Science
MetadataShow full item record
AbstractMetformin has been shown to repress transcription of the bile salt export pump (BSEP) in human primary hepatocytes. The primary objective of this study was to assess the effect of oral metformin on the human pharmacokinetics (PKs) of two BSEP probe substrates: pravastatin and chenodeoxycholic acid (CDCA; also known as chenodiol). Endogenous bile acid levels were assessed as a secondary measure of metformin impact. An open-label, randomized, single-dose, placebo-controlled, fasted, crossover PK study was conducted in 12 healthy adult volunteers. Metformin (500 mg b.i.d.) or placebo (b.i.d.) was administered orally for 6 days. On day 7, a single dose of the BSEP substrates pravastatin (80 mg) and CDCA (250 mg) were administered orally. Plasma samples were quantified for pravastatin, CDCA, and endogenous bile acids. Compared to placebo, metformin increased pravastatin plasma exposure, did not impact CDCA plasma exposure, and reduced conjugated primary bile acid levels in the blood. These results are consistent with metformin repressing BSEP expression. This differential effect reflects the degree of enterohepatic recirculation of victim substrates. © 2022 The Authors.
Rights/Terms© 2022 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/19572
- Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment.
- Authors: Cheng Y, Freeden C, Zhang Y, Abraham P, Shen H, Wescott D, Humphreys WG, Gan J, Lai Y
- Issue date: 2016 Jul
- Metformin Disrupts Bile Acid Efflux by Repressing Bile Salt Export Pump Expression.
- Authors: Garzel B, Hu T, Li L, Lu Y, Heyward S, Polli J, Zhang L, Huang SM, Raufman JP, Wang H
- Issue date: 2020 Jan 6
- Experimental Evidence of Liver Injury by BSEP-Inhibiting Drugs With a Bile Salt Supplementation in Rats.
- Authors: Yang F, Takeuchi T, Tsuneyama K, Yokoi T, Oda S
- Issue date: 2019 Jul 1
- Function and Expression of Bile Salt Export Pump in Suspension Human Hepatocytes.
- Authors: Chothe PP, Pemberton R, Hariparsad N
- Issue date: 2021 Apr
- Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor.
- Authors: Deng R, Yang D, Yang J, Yan B
- Issue date: 2006 Apr